Quintek Technologies, Inc., a global BPO provider and best-of-breed technology consultant, has received a signed agreement to deliver services nationally to a major biotechnology company.

Quintek received this new agreement after providing services to the company for over six months. The $12 billion per year biotechnology company is engaged in the discovery, development, manufacturing, and marketing of human therapeutics based on advances in cellular and molecular biology. For the new agreement, Quintek will expand to four sites to provide national services in the US for this customer.

Andrew Haag, CFO of Quintek, said, "The additional business should increase revenues from this account by over 100%. This additional business, from an existing customer, is a strong vote of confidence."

Robert Steele, CEO of Quintek, added, "This is a solid agreement, with fixed monthly minimum Billings. "We are currently delivering services for several multi-billion dollar customers that are leaders in their industry; we plan to grow the business around this model."

Image Source: www.wallstreetreporter.com